Navigation Links
$6.3 million center at UCSF and UC Davis seeks ways to diagnose and prevent osteoarthritis
Date:10/6/2011

How people walk, jump and run and how their knees look in an MRI scanner may hold the secret to predicting years or even decades in advance whether they will develop osteoarthritis, the common degenerative joint disease that strikes half of all Americans by the time they reach the age of 70.

Doctors today cannot look at a person's gait, leap, stride or scan and tell you definitively whether or not they will develop osteoarthritis, but a new translational research center at the University of California, San Francisco (UCSF) Medical Center and the University of California, Davis seeks to change this.

Funded by a $6.3 million grant from the National Institutes of Health, the center will bring together radiologists, orthopedic surgeons, rheumatologists, laboratory scientists, mathematicians and physical therapists under one umbrella with a single purpose: finding new tools for predicting and preventing osteoarthritis in young people and improving care and outcomes for the tens of millions of American adults already suffering from the disease.

"Osteoarthritis is one of the major age-related illnesses of our times, and there's no way to slow or reverse it once it starts," said Sharmila Majumdar, PhD, UCSF Professor in Residence and Vice-Chair of Research in the Department of Radiology and Biomedical Imaging. "The diverse group of experts at the center will all be seeking to address this problem, but from different perspectives, integrating imaging, biomechanics and the symptoms of the individual."

Specifically, these experts will combine advanced MRI imaging with sophisticated analyses of movement, clinical medicine, countrywide statistics and all the latest laboratory research on cartilage composition. They will seek to translate this research into clinical tools that can predict, prevent, and possibly slow damage to soft tissue in the joints.

"We're very excited about this research because it will allow us to assess the progressive degeneration and risk factors in osteoarthritis of the knee, identify its association with hip osteoarthritis, and determine how changes in cartilage may be a predictor for the disease," said professor Nancy E. Lane, MD, who leads the UC Davis Musculoskeletal Diseases of Aging Research Group, is co-principal investigator of the project and will direct one of the four major projects funded by the new grant.

The Appeal of Biomarkers to Medicine

An unfortunate reality of osteoarthritis is that the changes happening to the joints can go unnoticed for years. People in the early stages of the disease may not have any visible health problems, and much of the damage occurs long before someone develops soreness in their knees.

"By the time a patient sees a physician for walking knee pain, the disease is often very advanced," said Lane.

Part of the problem is that there is no effective way to screen for the earliest signs of osteoarthritis. X-rays taken of the knees and other joints are often inconclusive. While they may show the bones of a patient, they do not necessarily reveal the subtle changes to the soft tissue, where some of the earliest signs of disease may be hidden.

With some of the most advanced MRI imaging techniques now available, doctors can identify these subtle changes. Motivation for the new center stems from the fact that tools for identifying the early signs of osteoarthritis may already exist in laboratory, but more work needs to be done to push them into the clinic.

The new grant will fund several projects aimed at pushing the science forward by defining and standardizing biomarkers of the disease. These definitive, measurable quantities collected from something like a MRI scan would signal early joint degeneration.

According to Majumdar, the new center is uniquely positioned to define these biomarkers because developing them will require many experts from many different fields from experts in imaging to researchers who study patient movement and clinicians who see patients and recognize physical signs of disease.

Other center projects will utilize a treasure trove of osteoarthritis data gathered through a large national study, the Osteoarthritis Initiative sponsored by the National Institute of Arthritis and Musculo-Skeletal Disease (NIAMS).

Developing these biomarkers, Majumdar said, would be a boon for patients because, by giving pharmaceutical companies a useful way to test how effective the drugs are, it would speed up development of new drugs to fight osteoarthritis.


'/>"/>
Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-4608
University of California - San Francisco
Source:Eurekalert

Related medicine news :

1. Childhood asthma non-profit invests millions in health centers to help children better manage asthma
2. Penn receives $12.5 million from NIH to speed discovery to patient care
3. Campaign for Cancer Prevention connects 6 million+ members on Facebook Causes to research at BWH
4. UNC shares $6 million Leducq award to study heart failure
5. Cincinnati Childrens earns $12 million NIH grant to test migraine prevention medicines
6. Scripps research scientist wins $3.6 million NIH Method to Extend Research in Time award to study alcoholism in Native Americans
7. Wayne State researcher developing treatments for Parkinsons with aid of $2.15 million NIH grant
8. Boston researchers share in $10 million grant to study HIV and alcohol
9. Autism Speaks Autism Treatment Network receives $12 million AIR-P grant
10. US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research
11. Lung cancer research team awarded $1.43 million to study cancer in Eastern Kentucky
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: